智通财经APP讯，君实生物(01877)公布控股股东、实际控制人之一兼董事长增持股份进展，截至本公告披露日，熊俊先生通过上海证券交易所系统以集中竞价方式累计增持公司 A 股股份10万股，约占公司总股本的 0.01%，累计成交总额为人民币 383.84 万元。本次增持计划尚未实施完毕，熊俊先生将继续按照相关增持计划，在增持计划实施期间内择机增持公司股份。
智通财经APP讯，君实生物(01877)公布控股股东、实际控制人之一兼董事长增持股份进展，截至本公告披露日，熊俊先生通过上海证券交易所系统以集中竞价方式累计增持公司 A 股股份10万股，约占公司总股本的 0.01%，累计成交总额为人民币 383.84 万元。本次增持计划尚未实施完毕，熊俊先生将继续按照相关增持计划，在增持计划实施期间内择机增持公司股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.